Prognostic Value of Platelet-to-Monocyte Ratio for Mortality in HBV-Related Acute-on-Chronic Liver Failure

References

• Arroyo V, Moreau R, Jalan R. Acute-on-Chronic Liver Failure. N Engl J Med. 2020;382(22):2137–2145. doi:10.1056/NEJMra1914900
   PubMed Web of Science ®Google Scholar
• Bernal W, Jalan R, Quaglia A, Simpson K, Wendon J, Burroughs A. Acute-on-chronic liver failure. Lancet. 2015;386(10003):1576–1587. doi:10.1016/S0140-6736(15)00309-8
   PubMed Web of Science ®Google Scholar
• Jalan R, Williams R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif. 2002;20(3):252–261. doi:10.1159/000047017
   PubMed Web of Science ®Google Scholar
• Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut. 2018;67(12):2181–2191. doi:10.1136/gutjnl-2017-314641
   PubMed Web of Science ®Google Scholar
• Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353–390. doi:10.1007/s12072-019-09946-3
   PubMed Web of Science ®Google Scholar
• Wiesner R, Edwards E, Freeman R, et al. United network for organ sharing liver disease severity score committee. model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91–96. doi:10.1053/gast.2003.5001
   PubMed Web of Science ®Google Scholar
• Jalan R, Saliba F, Pavesi M, et al. CANONIC study investigators of the EASL-CLIF consortium. development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61(5):1038–1047. doi:10.1016/j.jhep.2014.06.012
   PubMed Web of Science ®Google Scholar
• Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis. 2002;2(1):43–50. doi:10.1016/s1473-3099(01)00172-4
   PubMed Web of Science ®Google Scholar
• Khanam A, Kottilil S. Acute-on-chronic liver failure: pathophysiological mechanisms and management. Front Med. 2021;8:752875. doi:10.3389/fmed.2021.752875
   PubMed Web of Science ®Google Scholar
• Mao T, Zhang B, Yang T, Qian Y, Zhou C, He C. Evaluation of five lymphocyte-based scores for prediction of mortality in hepatitis B virus-associated decompensated cirrhosis. Heliyon. 2023;9(8):e18556. doi:10.1016/j.heliyon.2023.e18556
   PubMed Web of Science ®Google Scholar
• Mao W, Wu J. Haematologic indices in hepatitis B virus-related liver disease. Clin Chim Acta. 2020;500:135–142. doi:10.1016/j.cca.2019.10.007
   PubMed Web of Science ®Google Scholar
• Bernsmeier C, Pop OT, Singanayagam A, et al. Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK. Gastroenterology. 2015;148(3):603–615.e14. doi:10.1053/j.gastro.2014.11.045
   PubMed Web of Science ®Google Scholar
• Bernsmeier C, Triantafyllou E, Brenig R, et al. CD14+ CD15− HLA-DR− myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure. Gut. 2018;67(6):1155–1167. doi:10.1136/gutjnl-2017-314184
   PubMed Web of Science ®Google Scholar
• Nwokediuko SC, Ibegbulam O. Quantitative platelet abnormalities in patients with hepatitis B virus-related liver disease. Gastroenterology Res. 2009;2(6):344–349. doi:10.4021/gr2009.12.132
   PubMedGoogle Scholar
• Bashour FN, Teran JC, Mullen KD. Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol. 2000;95(10):2936–2939. doi:10.1111/j.1572-0241.2000.02325.x
   PubMed Web of Science ®Google Scholar
• Lisman T, Luyendyk JP. Platelets as Modulators of Liver Diseases. Semin Thromb Hemost. 2018;44(2):114–125. doi:10.1055/s-0037-1604091
   PubMed Web of Science ®Google Scholar
• Dahlen B, Schulz A, Göbel S, et al. The impact of platelet indices on clinical outcome in heart failure: results from the MyoVasc study. ESC Heart Fail. 2021;8(4):2991–3001. doi:10.1002/ehf2.13390
   PubMed Web of Science ®Google Scholar
• Zhou J, Li X, Wang M, Gu C, Liu J. Platelet-to-monocyte ratio as a novel promising agent for the prognosis of hepatitis B virus-associated decompensated cirrhosis. Can J Gastroenterol Hepatol. 2023;2023:6646156. doi:10.1155/2023/6646156
   PubMed Web of Science ®Google Scholar
• Nikiforuk AM, Karim ME, Patrick DM, Jassem AN. Influence of chronic hepatitis C infection on the monocyte-to-platelet ratio: data analysis from the national health and nutrition examination survey (2009-2016). BMC Public Health. 2021;21(1):1388. doi:10.1186/s12889-021-11267-w
   PubMed Web of Science ®Google Scholar
• Kamath PS, Kim WR, Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD. Hepatology. 2007;45(3):797–805. doi:10.1002/hep.21563
   PubMed Web of Science ®Google Scholar
• Wu D, Sun Z, Liu X, et al. HINT: a novel prognostic model for patients with hepatitis B virus-related acute-on-chronic liver failure. Aliment Pharmacol Ther. 2018;48(7):750–760. doi:10.1111/apt.14927
   PubMed Web of Science ®Google Scholar
• Zhang Y, Nie Y, Liu L, Zhu X. Assessing the prognostic scores for the prediction of the mortality of patients with acute-on-chronic liver failure: a retrospective study. PeerJ. 2020;8:e9857. doi:10.7717/peerj.9857
   PubMed Web of Science ®Google Scholar
• Li H, Zheng J, Chen L, Cai J, Zhang M, Wang G. The scoring systems in predicting short-term outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure. Ann Palliat Med. 2020;9(5):3048–3058. doi:10.21037/apm-20-608
   PubMed Web of Science ®Google Scholar
• Kuo NR, Hou MC, Chu WC, et al. Low lymphocyte-to-monocyte ratio, calcitriol level, and CD206 level predict the development of acute-on-chronic liver failure in patients cirrhosis with acute decompensation. J Chin Med Assoc. 2023;86(3):265–273. doi:10.1097/JCMA.0000000000000867
   PubMed Web of Science ®Google Scholar
• Cai YJ, Dong JJ, Dong JZ, et al. A nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute-on-chronic liver failure. Aliment Pharmacol Ther. 2017;45(11):1413–1426. doi:10.1111/apt.14046
   PubMed Web of Science ®Google Scholar
• Lou Y, Wang M, Mao W. Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B. PLoS One. 2012;7(5):e37644. doi:10.1371/journal.pone.0037644
   PubMed Web of Science ®Google Scholar
• Geng A, Flint E, Bernsmeier C. Plasticity of monocytes and macrophages in cirrhosis of the liver. Front Netw Physiol. 2022;2:937739. doi:10.3389/fnetp.2022.937739
   PubMedGoogle Scholar
• Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011;11(11):762–774. doi:10.1038/nri3070
   PubMed Web of Science ®Google Scholar
• Berry PA, Antoniades CG, Carey I, et al. Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis. Intensive Care Med. 2011;37(3):453–460. doi:10.1007/s00134-010-2099-7
   PubMed Web of Science ®Google Scholar
• Landolfi R, Leone G, Fedeli G, Storti S, Laghi F, Bizzi B. Platelet-associated IgG in acute and chronic hepatic diseases. Scand J Haematol. 1980;25(5):417–422. doi:10.1111/j.1600-0609.1981.tb01423.x
   PubMedGoogle Scholar
• Karasu Z, Tekin F, Ersoz G, et al. Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C. Dig Dis Sci. 2007;52(6):1535–1539. doi:10.1007/s10620-006-9144-y
   PubMed Web of Science ®Google Scholar
• Jie Y, Gong J, Xiao C, et al. Low platelet to white blood cell ratio indicates poor prognosis for acute-on-chronic liver failure. Biomed Res Int. 2018;2018:7394904. doi:10.1155/2018/7394904
   PubMed Web of Science ®Google Scholar
• Hisakura K, Murata S, Takahashi K, et al. Platelets prevent acute hepatitis induced by anti-fas antibody. J Gastroenterol Hepatol. 2011;26(2):348–355. doi:10.1111/j.1440-1746.2010.06334.x
   PubMed Web of Science ®Google Scholar
• Lin W, Zhang J, Liu X, et al. A dynamic model for predicting outcome in patients with hbv related acute-on-chronic liver failure. Ann Hepatol. 2018;17(3):392–402. doi:10.5604/01.3001.0011.7383
   PubMed Web of Science ®Google Scholar
• Shi X, Zhu P, Yan G, et al. Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure. J Viral Hepat. 2016;23(11):920–929. doi:10.1111/jvh.12566
   PubMed Web of Science ®Google Scholar